- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/94 - Nitrogen atoms
Patent holdings for IPC class C07D 239/94
Total number of patents in this class: 707
10-year publication summary
|
42
|
44
|
34
|
40
|
42
|
27
|
55
|
47
|
37
|
24
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Araxes Pharma LLC | 92 |
18 |
| The Regents of the University of California | 20303 |
16 |
| Boehringer Ingelheim International GmbH | 4636 |
13 |
| NATCO Pharma Limited | 204 |
11 |
| Gilead Sciences, Inc. | 2106 |
10 |
| Bristol-myers Squibb Company | 4826 |
8 |
| Genentech, Inc. | 4016 |
8 |
| Janssen Pharmaceutica N.V. | 3358 |
7 |
| CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 201 |
7 |
| Dana-Farber Cancer Institute, Inc. | 2626 |
7 |
| Merck Patent GmbH | 5752 |
6 |
| The Trustees of Columbia University in the City of New York | 3604 |
6 |
| Northwestern University | 3457 |
6 |
| Asana Biosciences, LLC | 43 |
6 |
| Chiesi Farmaceutici S.p.A. | 973 |
6 |
| Council of Scientific & Industrial Research | 1426 |
6 |
| Evotec International GmbH | 87 |
6 |
| Institute of Organic Chemistry and Biochemistry of the AS CR, v.v.i. | 13 |
6 |
| The Scripps Research Institute | 1355 |
6 |
| Shanghai Allist Pharmaceuticals, Inc. | 24 |
6 |
| Other owners | 542 |